These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9244966)

  • 1. [Kidney colic under Indinavir [correction of indiavir] therapy in HIV infection].
    Junghanss BG
    Praxis (Bern 1994); 1997 Apr; 86(18):767-8. PubMed ID: 9244966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of complicated renal colic in patients treated with indinavir: value of double J stents].
    Van Glabeke E; Conort P; Chartier-Kastler E; Desrez G; Boyer C; Richard F
    Prog Urol; 1999 Jun; 9(3):470-3. PubMed ID: 10434319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indinavir-induced renal failure.
    Chen SC; Nankivell BJ; Dwyer DE
    AIDS; 1998 Mar; 12(4):440-1. PubMed ID: 9520176
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
    Hirsch MS; Steigbigel RT; Staszewski S; McMahon D; Fischl MA; Hirschel B; Squires K; DiNubile MJ; Harvey CM; Chen J; Leavitt RY;
    Clin Infect Dis; 2003 Oct; 37(8):1119-24. PubMed ID: 14523778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index.
    Meraviglia P; Angeli E; Del Sorbo F; Rombolà G; Viganò P; Orlando G; Cordier L; Faggion I; Cargnel A
    AIDS; 2002 Oct; 16(15):2089-93. PubMed ID: 12370513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecomastia during indinavir antiretroviral therapy in HIV infection.
    Toma E; Therrien R
    AIDS; 1998 Apr; 12(6):681-2. PubMed ID: 9583616
    [No Abstract]   [Full Text] [Related]  

  • 11. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
    Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P
    Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indinavir-associated lipodystrophy].
    Krautheim A
    Praxis (Bern 1994); 1999 Feb; 88(7):285-7. PubMed ID: 10097649
    [No Abstract]   [Full Text] [Related]  

  • 13. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ritonavir and indinavir one year later.
    TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nephritic colic due to indinavir].
    Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir.
    Grunke M; Valerius T; Manger B; Kalden JR; Harrer T
    Clin Infect Dis; 1997 Nov; 25(5):1270-1. PubMed ID: 9402412
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 18. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
    Hester EK; Peacock JE
    AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 20. Subtle occurrence of indinavir-induced acute renal insufficiency.
    Viganò A; Rombolà G; Barbiano di Belgioioso G; Sala N; Principi N
    AIDS; 1998 May; 12(8):954-5. PubMed ID: 9631152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.